Articles

Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome

Department of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Stockholm, Sweden;Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Department of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Stockholm, Sweden;Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Department of Pediatric Oncology, Uppsala University Hospital, Sweden
Department of Pediatrics, Umeå University Hospital, Sweden
Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Sweden;Clinical Epidemiology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden;Department of Epidemiology and Public Health, University College London, UK
Unit of Biostatistics, IMM, Karolinska Institutet, Stockholm, Sweden
Department of Pediatric Oncology, Rigshospitalet University Hospital, Copenhagen, Denmark
Department of Pediatrics, Odense University Hospital, Denmark
Department of Pediatrics, Ullevål Hospital, Oslo, Norway
Department of Pediatrics, Turku University Hospital, Turku, Finland
Children’s Hospital, University of Helsinki and Helsinki University Central Hospital, Finland
Children’s Hospital, Landspitali University Hospital, Reykjavik, Iceland
Department of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Stockholm, Sweden;Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Vol. 101 No. 1 (2016): January, 2016 https://doi.org/10.3324/haematol.2015.131680